P.3.006 A double-blind, placebo-controlled trial ofvenlafaxine XR in the short-term treatment of panic disorder

2004 ◽  
Vol 14 ◽  
pp. S305-S306 ◽  
Author(s):  
M.R. Liebowitz ◽  
G. Asnis ◽  
E. Tzanis ◽  
T. Whitaker
1991 ◽  
Vol 21 (4) ◽  
pp. 991-998 ◽  
Author(s):  
Greg Wilkinson ◽  
Matteo Balestrieri ◽  
Mirella Ruggeri ◽  
Cesario Bellantuono

SYNOPSISMeta-analysis of 19 double-blind placebo-controlled trials of antidepressants (N = 13) and benzodiazepines (N = 6) for patients with panic disorders showed that active treatment had 25% greater success rate than placebo over a mean duration of 14 weeks. There were no statistically significant differences observed between treatment sub-groups (antidepressants – mean duration 16 weeks; and benzodiazepines – mean duration 7 weeks). On this basis antidepressants and benzodiazepines prescribed in clinical settings are likely to be equally effective in the short-term treatment of people with panic disorders.


BMJ ◽  
1979 ◽  
Vol 2 (6181) ◽  
pp. 17-17 ◽  
Author(s):  
G B Porro ◽  
G Dobrilla ◽  
G Verme ◽  
M Gallo ◽  
M Petrillo ◽  
...  

1985 ◽  
Vol 28 (2) ◽  
pp. 177-180 ◽  
Author(s):  
C. Hüscher ◽  
G. Magni ◽  
A. Salmi ◽  
S. Bossini ◽  
C. Felini ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document